Editorial: Cancer immunotherapy.
D000951:Antigens, Neoplasm; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012042:Registries; D013601:T-Lymphocytes / Q000276:immunology; D014481:United States
D000951:Antigens, Neoplasm